PRFX
NASDAQ · Pharmaceuticals
Prf Technologies Ltd
$2.30
+0.10 (+4.55%)
Financial Highlights (FY 2025)
Revenue
3.33M
Net Income
722.6K
Gross Margin
53.5%
Profit Margin
21.7%
Rev Growth
-7.5%
D/E Ratio
0.57
Revenue & Net Income
Margin Trends
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Gross Margin | 53.5% | 53.5% | 53.5% |
| Operating Margin | 31.4% | 29.8% | 28.9% |
| Profit Margin | 21.7% | 23.3% | 21.9% |
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 3.33M | 3.45M | 3.63M |
| Gross Profit | 1.78M | 1.85M | 1.94M |
| Operating Income | 1.04M | 1.03M | 1.05M |
| Net Income | 722.6K | 805.0K | 796.5K |
| Gross Margin | 53.5% | 53.5% | 53.5% |
| Operating Margin | 31.4% | 29.8% | 28.9% |
| Profit Margin | 21.7% | 23.3% | 21.9% |
| Rev Growth | -7.5% | +9.4% | +15.6% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 4.88M | 5.12M | 5.00M |
| Total Equity | 8.55M | 7.87M | 7.95M |
| D/E Ratio | 0.57 | 0.65 | 0.63 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 1.33M | 1.25M | 1.35M |
| Free Cash Flow | 449.2K | 396.5K | 453.1K |